<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Med | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-18T13:21:42+08:00</updated>
  <subtitle>Best Evidence, Best Benefit</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>MSI-H/dMMR晚期实体瘤：各家PD-1/PD-L1表现如何？</title>
    <updated>2020-11-18T10:36:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/GPlvL7kFhVvjuUejgyStEg</id>
    <link href="https://mp.weixin.qq.com/s/GPlvL7kFhVvjuUejgyStEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDK4/6抑制剂角逐早期乳腺癌：阿贝西利为何后来居上？</title>
    <updated>2020-11-16T11:17:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/S6sPluIOJjFD7Xmd8UDPDA</id>
    <link href="https://mp.weixin.qq.com/s/S6sPluIOJjFD7Xmd8UDPDA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ALK抑制剂一线PK，哪个更好？</title>
    <updated>2020-11-13T10:24:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/hNBBxRdtQ60GeNMZZ30spQ</id>
    <link href="https://mp.weixin.qq.com/s/hNBBxRdtQ60GeNMZZ30spQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肺癌研究月报 | 2020年10月</title>
    <updated>2020-11-11T10:45:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/73YTFD93oY6T1gqa-GvLGw</id>
    <link href="https://mp.weixin.qq.com/s/73YTFD93oY6T1gqa-GvLGw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>他山之石，可以攻玉：中国肺癌生存飞跃的“三板斧”</title>
    <updated>2020-11-09T10:05:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/w076jtk3DZ1QLsK7CDU3iA</id>
    <link href="https://mp.weixin.qq.com/s/w076jtk3DZ1QLsK7CDU3iA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球肿瘤新药重磅临床进展 | 2020年10月</title>
    <updated>2020-11-06T12:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/RqQZYsjgUYp27A9KsQ4wvw</id>
    <link href="https://mp.weixin.qq.com/s/RqQZYsjgUYp27A9KsQ4wvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>临床研究月报 | 2020年10月</title>
    <updated>2020-11-04T13:45:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/JVK-KnYW-1ajUVFFRp_fSA</id>
    <link href="https://mp.weixin.qq.com/s/JVK-KnYW-1ajUVFFRp_fSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>风云雄霸天下，晚期胃癌一线免疫治疗谁与争锋？</title>
    <updated>2020-11-02T09:43:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/uRpfYIRKSAdDNT-TQA_RlQ</id>
    <link href="https://mp.weixin.qq.com/s/uRpfYIRKSAdDNT-TQA_RlQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>临床试验那些事：I期剂量探索试验中关于药物联合治疗的所思所想</title>
    <updated>2020-10-29T09:27:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/mwepeoPNTKZ_4ApOiC4Q3Q</id>
    <link href="https://mp.weixin.qq.com/s/mwepeoPNTKZ_4ApOiC4Q3Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>KRAS抑制剂对比：MRTX849比AMG510更好吗？</title>
    <updated>2020-10-27T12:21:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/P2GToBPxv7_gieXIHJglGQ</id>
    <link href="https://mp.weixin.qq.com/s/P2GToBPxv7_gieXIHJglGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>